Medicine & Life Sciences
Equilibrative Nucleoside Transporter 1
100%
Plasmodium vivax
73%
Drug Development
53%
Inhibitory Concentration 50
32%
Plasmodium falciparum
32%
purine
17%
4-nitrobenzylthioinosine
17%
Yeasts
16%
Pyrimidines
14%
Purines
13%
Inosine
13%
Uridine
12%
Adenosine
10%
Malaria
9%
Parasites
8%
Nucleoside Transport Proteins
7%
High-Throughput Screening Assays
7%
Cytidine
7%
Vivax Malaria
7%
Hypoxanthine
6%
Guanosine
6%
Dipyridamole
6%
Falciparum Malaria
5%
Nucleosides
5%
Codon
5%
Thymidine
4%
Saccharomyces cerevisiae
4%
Single Nucleotide Polymorphism
4%
Erythrocytes
4%
Infections
2%
Genes
2%
Agriculture & Biology
drug development
71%
antimalarials
68%
nucleosides
60%
transporters
48%
Plasmodium falciparum
28%
inhibitory concentration 50
24%
purines
20%
malaria
12%
yeasts
10%
inosine
10%
pyrimidines
9%
uridine
8%
adenosine
8%
falciparum malaria
6%
dipyridamole
5%
parasites
5%
cytidine
5%
new drugs
4%
nucleobases
4%
hypoxanthine
4%
guanosine
4%
drug therapy
4%
thymidine
3%
imports
3%
codons
3%
single nucleotide polymorphism
3%
Saccharomyces cerevisiae
3%
erythrocytes
3%
uptake mechanisms
2%
assays
2%
infection
2%
genes
1%